Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Binx Health

Explore full profile

Creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most

Trowbridge, United KingdomFounded 2005Health Tech & Medtech
Valuation $500M–1B Last recorded · 2024
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Binx Health and the history behind them.

About Binx Health

binx health is a healthcare startup that operates in the diagnostic solutions market, providing point-of-care testing services. The company's primary focus is on enhancing community health outcomes by offering high-quality, timely diagnostic solutions that are tailored to the preferred care settings of patients. binx health's services are particularly relevant in today's healthcare landscape, where the way people consume healthcare is rapidly changing.

The company's primary product, binx io, is a molecular point-of-care testing platform. This platform is designed to enable single-visit diagnosis and treatment of chlamydia and gonorrhea infections, two common sexually transmitted diseases. This means that patients can receive a diagnosis and begin treatment in a single visit, improving the efficiency of healthcare delivery and potentially leading to better health outcomes.

binx health's business model is centered on partnering with healthcare providers to expand convenient and equitable access to healthcare. By offering point-of-care diagnostic solutions, binx health helps its partners to overcome traditional barriers to care, extend their reach, and provide exceptional patient experiences. The company generates revenue by selling its diagnostic solutions to these healthcare providers.

In terms of its market, binx health operates in the broader healthcare sector, with a specific focus on diagnostic services. The company's clients are primarily healthcare providers who are looking to improve their diagnostic capabilities and patient care.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2005
Headquarters
Trowbridge, United Kingdom
Employees
93
Open positions
7
Dealroom signal
80.9/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Testing, Sustainable Development Goals, Sextech, Tech for Patients, Hard Tech, Digital Care, medical testing, uk is8 life sciences
Business model
Manufacturing
Client focus
b2c

Funding history

10 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES FOther financing Apr 2024 $65M $520M Hildred Capital · EQT Life Sciences ↗
SERIES EOther financing May 2021 $104M $416M Johnson & Johnson Development Corporation · Alta Life Sciences · ArrowMark Partners · Hildred Capital Partners —
Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Binx Health website traffic

Latest recorded traffic for Binx Health is 5.7K monthly website visits, down 21.9% over the last three months. Binx Health's team grew 1.1% over the past year.

Latest monthly visits5.7K 3-month web change-21.9% 1-year team growth+1.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

20 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Wellcome Trust
  • UK National Institute for Health Research

Series A10 investors entered at this stage

  • Braveheart Investment Group
  • Technology Venture Partners
  • Novartis Venture Fund
  • Johnson & Johnson
  • Global Life Science Ventures
  • BB Biotech Ventures
  • Consort Medical
  • EQT Life Sciences
  • Johnson & Johnson Development Corporation
  • YFM Equity Partners

Series B and later8 investors entered at this stage

  • RMI Partners
  • Novartis
  • Alta Life Sciences
  • OrbiMed
  • ArrowMark Partners
  • Hildred Capital Partners
  • Parian Global Management
  • Hildred Capital
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States57.5%
🇬🇧 United Kingdom41.1%
🇪🇸 Spain1.4%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Binx Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Binx Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.